Subscribe to RSS
DOI: 10.1055/s-2007-980356
Preliminary Studies on the Michael Addition of Quinones to Nitroolefins: (6bR,10aS)-7,8,9,10,10a,11-Hexahydro-6bH-benzo[a]carbazole-5,6-diones, (4aR,11bS)-1,2,3,4,4a,5-Hexahydro-11bH-benzo[b]carbazole-6,11-diones, and 1,2,3,4-Tetrahydro-5H-benzo[b]carbazole-6,11-diones
Publication History
Publication Date:
23 May 2007 (online)
Abstract
We describe herein preliminary results on the novel Michael addition of naphthoquinones to nitroolefins and its application to the first synthesis of the novel (6bR,10aS)-7,8,9,10,10a,11-hexahydro-6bH-benzo[a]carbazole-5,6-diones and (4aR,11bS)-1,2,3,4,4a,5-hexahydro-11bH-benzo[b]carbazole-6,11-diones, together with a novel synthesis of 1,2,3,4-tetrahydro-5H-benzo[b]carbazole-6,11-diones.
Key words
annulations - asymmetric synthesis - cyclization - indoles - Michael additions - quinones
-
1a
Barret AGM.Graboski GG. Chem. Rev. 1986, 86: 751 - 1b Nitroalkanes and Nitroalkenes in Synthesis, In Tetrahedron Symposia-in-Print; Barret, A. G. M., Ed.Tetrahedron 1990, 46: 7313
-
1c
Noboru O. In The Nitro Group in Organic SynthesisFeuer H. Organic Nitro Chemistry Series, Wiley-VCH; New York: 2001. -
2a
The Chemistry of Functional Groups: The Chemistry of The Quinoid Compounds
Patai S.Rappoport Z. Wiley; New York: 1988. -
2b
Thomson RH. Naturally Occurring Quinones 4th ed.: Chapman and Hall; London: 1997. - 3
Cheng CC. Structural Aspects of Antineoplastic Agents - A New Approach, In Progress in Medicinal Chemistry Vol. 25:Ellis GP.West GB. Elsevier; Amsterdam: 1988. p.pp 35-83 -
4a
Gould SJ. Chem. Rev. 1997, 97: 2499 -
4b
Marco-Contelles J.Molina M. Curr. Org. Chem. 2003, 7: 1433 - 5
Harwood JS.Harwood CA. J. Org. Chem. 2004, 69: 5128 - 6
Yu M.Malinakova HC.Stagliano KN. J. Org. Chem. 2006, 71: 6648 -
7a
Estévez JC.Estévez RJ.Castedo L. Tetrahedron Lett. 1993, 34: 6479 -
7b
Cruces J.Estévez JC.Castedo L.Estévez RJ. Tetrahedron Lett. 2001, 42: 4825 -
7c
Cruces J.Martínez E.Treus M.Martínez LA.Estévez JC.Estévez RJ.Castedo L. Tetrahedron 2002, 58: 3015 -
7d
Barcia JC.Cruces J.Estévez JC.Estévez RJ.Castedo L. Tetrahedron Lett. 2002, 43: 5141 -
7e
Fernández M.Barcia C.Estévez JC.Estévez RJ.Castedo L. Synlett 2004, 267 -
7f
Otero JM.Barcia JC.Estévez JC.Estévez RJ. Tetrahedron: Asymmetry 2005, 16: 11 - 8
Corey EJ.Estreicher H. J. Am. Chem. Soc. 1978, 100: 6294 - 10
Kobayasi K.Taki T.Kawakita M.Uchida M.Morikawa O.Konishi H. Heterocycles 1999, 51: 349 - For previous similar cyclizations leading to oxygen heterocycles, see:
-
11a
Lee YR.Kang KY.Lee GJ.Lee WK. Synthesis 2003, 1977 -
11b
Lee YR.Kim BS. Synth. Commun. 2003, 33: 4123 -
11c
Nair W.Treesa PM.Maliakal D.Rath NP. Tetrahedron 2001, 57: 7705 -
12a
Kobayashi K.Takeuchi H.Seko S.Suginome H. Helv. Chim. Acta 1991, 74: 1091 -
12b
Sullivan PJ.Moreno R.Murphy WS. Tetrahedron Lett. 1992, 33: 535 -
12c
Kobayashi K.Takeuchi H.Seko S.Kanno Y.Kujime SH.Suginome S. Helv. Chim. Acta 1993, 76: 2942 -
12d
Mithani S.Weeratunga G.Taylor NJ.Dmitrienko GI. J. Am. Chem. Soc. 1994, 116: 2209 -
12e
Tanaka K.Takanohashi A.Morikawa O.Konishi H.Kobayashi K. Heterocycles 2001, 55: 1561 -
12f
Wu Y.-L.Chuang C.-P.Lin P.-Y. Tetrahedron 2001, 57: 5543 - 13
Kitani Y.Morita A.Kumamoto T.Ishikawa T. Helv. Chim. Acta 2002, 85: 1186
References and Notes
All new compounds gave satisfactory analytical and spectroscopic data. Selected physical and spectroscopic data follow.
Compound 6: mp 181-183 °C (MeOH). IR (NaCl): ν = 1673 (C=O), 1644 (C=O), 1540 (NO2), 1367 (NO2) cm-1. 1H NMR (CDCl3): δ = 1.38-1.64 (m, 2 H, CH2), 1.73-2.08 (m, 5 H, 2 × CH2 and CHH), 2.33-2.51 (m, 1 H, CHH), 3.71 (td, J = 11.6, 4.0 Hz, 1 H, CH), 5.40 (td, J = 11.6, 4.0 Hz, 1 H, CHNO2), 7.67 (td, J = 7.6, 1.5 Hz, 1 H, ArH), 7.76 (td, J = 7.6, 1.5 Hz, 1 H, ArH), 8.05 (dd, J = 7.6, 1.5 Hz, 1 H, ArH), 8.11 (dd, J = 7.6, 1.5 Hz, 1 H, ArH) ppm. 13C NMR (CDCl3): δ = 24.2 (CH2), 25.0 (CH2), 28.4 (CH2), 32.1 (CH2), 38.5 (CH), 85.9 (CHNO2), 121.6 (C), 126.2 (CH), 127.0 (CH), 129.0 (C), 132.7 (C), 133.1 (CH), 135.2 (CH), 153.4 (C), 181.0 (C=O), 183.7 (C=O) ppm. MS-FAB: m/z (%) = 302 (12) [MH+], 137 (100).
Compound 8: IR (NaCl): ν = 2935 (NH), 1681 (C=O) cm-1. 1H NMR (DMSO): δ = 1.16-2.27 (m, 8 H, 4 × CH2), 2.50-2.65 (m, 1 H, CH), 3.43-3.59 (m, 1 H, CH), 7.57-7.94 (m, 4 H, 4 × ArH), 9.21 (br s, 1 H, NH) ppm. 13C NMR (DMSO): δ = 24.3 (CH2), 25.3 (CH2), 28.4 (CH2), 30.0 (CH2), 47.5 (CH), 67.7 (CH), 115.7 (C), 124.2 (CH), 127.4 (C), 127.7 (CH), 131.5 (C), 131.6 (CH), 133.9 (CH), 161.1 (C), 171.2 (C=O), 183.6 (C=O) ppm. MS: m/z (%) = 253 (63) [M+], 195 (100).
Compound 9: IR (NaCl): ν = 2931 (NH), 1670 (C=O), 1628 (C=O) cm-1. 1H NMR (acetone): δ = 1.28-1.92 (m, 6 H, 3 × CH2), 2.20-2.31 (m, 1 H, CH), 2.56-2.74 (m, 2 H, CH2), 3.19-3.33 (m, 1 H, CH), 6.65 (br s, 1 H, NH), 7.68 (td, 1 H, J = 7.5, 1.6 Hz, ArH), 7.76 (td, 1 H, J = 7.5, 1.6 Hz, ArH), 7.91-7.99 (m, 2 H, 2 × ArH) ppm. 13C NMR (acetone): δ = 26.3 (CH2), 27.6 (CH2), 30.6 (CH2), 32.7 (CH2), 50.7 (CH), 70.3 (CH), 124.5 (C), 127.0 (CH), 127.1 (CH), 133.6 (CH), 135.8 (C), 135.9 (CH), 136.2 (C), 156.4 (C), 181.5 (C=O), 182.0 (C=O) ppm. MS: m/z (%) = 253 (91) [M+], 224 (100).
Compound 11a: mp 120-122 °C (MeOH). 1H NMR (CDCl3): δ = 1.45-2.18 (m, 6 H, 3 × CH2), 2.28-2.47 (m, 1 H, CHH), 2.53-2.74 (m, 1 H, CHH), 3.59 (dt, J = 13.0, 3.9 Hz, 1 H, CHAr), 3.91 (s, 3 H, OCH3), 3.96 (s, 3 H, OCH3), 5.07-5.16 (m, 1 H, CHNO2), 6.67 (s, 1 H, ArH), 7.43-7.59 (m, 2 H, 2 × ArH), 8.02 (d, J = 8.0 Hz, 1 H, ArH), 8.23 (d, J = 7.3 Hz, 1 H, ArH) ppm. 13C NMR (CDCl3): δ = 19.9 (CH2), 25.1 (CH2), 25.5 (CH2), 30.5 (CH2), 39.0 (CH), 55.6 (OCH3), 62.3 (OCH3), 86.1 (CHNO2), 102.6 (CH), 121.9 (CH), 122.4 (CH), 125.3 (CH), 125.9 (C), 126.5 (CH), 127.9 (C), 128.6 (C), 146.7 (C), 151.9 (C) ppm. MS: m/z (%) = 315 (100) [M+].
Compound 11b: mp 109-110 °C (MeOH). 1H NMR (CDCl3): δ = 1.42-2.14 (m, 6 H, 3 × CH2), 2.28-2.44 (m, 1 H, CHH), 2.50-2.69 (m, 1 H, CHH), 3.53 (dt, J = 13.1, 3.9 Hz, 1 H, CHAr), 3.85 (s, 3 H, OCH3), 3.92 (s, 3 H, OCH3), 3.95 (s, 3 H, OCH3), 5.06-5.13 (m, 1 H, CHNO2), 6.69 (s, 1 H, ArH), 6.84 (d, J = 7.9 Hz, 1 H, ArH), 7.40 (t, J = 7.9 Hz, 1 H, ArH), 7.62 (d, J = 7.9 Hz, 1 H, ArH) ppm. 13C NMR (CDCl3): δ = 19.8 (CH2), 25.0 (CH2), 25.4 (CH2), 30.5 (CH2), 38.9 (CH), 56.3 (OCH3), 56.8 (OCH3), 62.0 (OCH3), 85.9 (CH-NO2), 105.3 (CH), 106.2 (CH), 114.7 (CH), 117.8 (C), 126.6 (CH), 129.3 (C), 130.7 (C), 146.7 (C), 153.4 (C), 157.3 (C) ppm. MS: m/z (%) = 346 (94) [MH+], 299 (100).
Compound 15b: mp 300-301 °C (dec., CHCl3). 1H NMR (DMSO): δ = 1.60-1.82 (m, 4 H, 2 × CH2), 2.49-2.68 (m, 4 H, 2 × CH2), 4.03 (s, 3 H, OCH3), 7.20-7.31 (m, 1 H, ArH), 7.59-7.73 (m, 2 H, 2 × ArH), 11.95 (br s, 1 H, NH) ppm. 13C NMR (DMSO): δ = 21.5 (CH2), 22.0 (CH2), 22.2 (CH2), 22.6 (CH2), 56.0 (OCH3), 117.8 (C), 120.0 (C), 126.5 (CH), 128.8 (C), 130.0 (CH), 130.3 (C), 134.0 (C), 135.7 (CH), 139.2 (C), 158.7 (C), 176.3 (C=O), 181.3 (C=O) ppm. MS: m/z (%) = 281 (100) [M+].